Yahoo Finance report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Why DHR Stock dropped -2.00% Today — RQD Quant Desk Flash
Danaher Corporation (DHR) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (59% profit margin, 6% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is DHR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Danaher Corporation (NYSE: DHR) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $232.23 (-2.00% 1D, market cap $166.72B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 19/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 11/20. Across 485 tracked Industrials issuers, DHR ranks #44 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does DHR compare to DE and TMO in the Industrials sector?
▼
Within the Industrials sector (Industrial Machinery/Components), DHR carries a Roarable B- (70/100 RQD), trailing P/E of 46.1x, gross margin of 59.1%, and ROIC of 6.1%. By comparison, DE (Deere & Company) holds a C+ grade (66/100 RQD, P/E 35.4x, ROIC 9.3%, cap $177.95B) and TMO (Thermo Fisher Scientific Inc) posts a B grade (73/100 RQD, P/E 39.0x, ROIC 9.3%, cap $262.22B). Among the 5-stock peer group, ITW leads on earnings multiple (24.3x) while ITW leads on capital efficiency (23.4% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for DHR?
▼
Per DHR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000313616), Danaher Corporation generated $24.57B in revenue (+2.9% YoY), $3.61B in net income, and $5.26B in free cash flow against $83.46B in total assets and $18.42B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 46x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±5.8% realized swing band)
Altman Z-Score 3.85 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
Cannibal Buyback (-0.96% YoY Shares) & executive Form 4 sales trim 9 pts from alignment
⚔️ Adversarial Opposing Case: Why the DHR Bull Thesis Could Fail
Even with a 70/100 (B-) score, DHR faces multiple-compression risk if 46.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Priced at 46x earnings—high expectations leave less room for a lukewarm quarter.
Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 56.6% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($219.65) or 200D SMA ($201.10) invalidates the momentum regime and cuts Target Base ($244.77) toward Bear Floor ($190.43).
Why DHR Stock dropped -2.00% Today — RQD Quant Desk Flash
Danaher Corporation (DHR) dropped -2.00% to $232.23, trading at 87% of its 52-week range ($160.93 – $242.8). High-quality cash engine (59% profit margin, 6% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 87% of its 52-week range ($160.93 – $242.8) with RSI-14 at 62.5 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±5.8% around $232.23 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B- (Buy) backed by 59.1% gross margin and $5.3B annual free cash flow.
Seeking Alpha report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Benzinga report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Kalkine Media report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
R&D investment, CRISPR, NGS, personalized medicine and diagnostics drive demand, while strategic partnerships accelerate reagent innovation and commercialization.Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) -- "Biotechnology R
AMETEK (NYSE:AME) is scheduled to report its earnings on Tuesday, November 3, 2026. The company has a market value of about $55.2 billion. Over the last twelve months it generated $7.9 billion in revenue and $2.0 billion
Scheduled RQD Strong Buys & Whale Accumulation Briefing (DHR Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
DHR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +2.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on DHR today. View full Setup Ledger →
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DHR)
1. Head-to-Head Industrials Peer Comparison (DHR vs. DE, TMO, JCI, ITW)
Industry: Industrial Machinery/Components (208 Tracked Issuers)Across 485 tracked Industrials securities in the Roarable RQD universe, Danaher Corporation (DHR) ranks #44 by composite RQD confidence (70/100, grade B-) and #6 by equity capitalization ($166.72B). Within this direct 5-issuer industry benchmark cohort, ITW leads on earnings valuation at 24.3x trailing P/E, while ITW leads on capital efficiency and profitability with 23.4% ROIC and 52.9% gross margin. ITW currently holds the highest overall quantitative score in the immediate peer group at 76/100 (B+) compared with DHR at 70/100 (B-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| DHR
ACTIVE
Danaher Corporation | B- | 70/100 | 46.1x | 59.1% | 6.1% | -2.00% | $166.72B | Benchmark Subject |
| DE Deere & Company | C+ | 66/100 | 35.4x | — | 9.3% | +2.35% | $177.95B | /de-vs-dhr → |
| TMO Thermo Fisher Scientific Inc | B | 73/100 | 39.0x | — | 9.3% | -1.72% | $262.22B | /tmo-vs-dhr → |
| JCI Johnson Controls International plc Ordinary Share | B | 73/100 | 29.1x | 36.4% | 15.6% | -5.84% | $95.87B | /jci-vs-dhr → |
| ITW Illinois Tool Works Inc. | B+ | 76/100 | 24.3x | 52.9% | 23.4% | -1.01% | $79.97B | /itw-vs-dhr → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000313616In its most recent audited fiscal period (FY2025, filed 2025-12-31), Danaher Corporation (DHR) reported GAAP revenue of $24.57B (+2.9% vs. FY2024 revenue of $23.88B , and +2.8% cumulative change since FY2023) , GAAP net income of $3.61B, operating cash flow of $6.42B, and free cash flow of $5.26B (-0.7% YoY). On the balance sheet, DHR closed FY2025 with $83.46B in total assets against $18.42B in total debt (Altman Z-Score: 3.85, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $24.57B | $3.61B | $6.42B | $5.26B | $83.46B | $18.42B |
| FY2024 (FY) | 2024-12-31 | $23.88B | $3.90B | $6.69B | $5.30B | $77.54B | $15.50B |
| FY2023 (FY) | 2023-12-31 | $23.89B | $4.76B | $7.16B | $6.09B | $91.70B | $21.46B |
3. DHR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs DHR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Danaher Corporation (NYSE: DHR) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $232.23 (-2.00% 1D, market cap $166.72B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 19/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 11/20. Across 485 tracked Industrials issuers, DHR ranks #44 in composite RQD confidence.
How does DHR compare to DE and TMO in the Industrials sector?
Within the Industrials sector (Industrial Machinery/Components), DHR carries a Roarable B- (70/100 RQD), trailing P/E of 46.1x, gross margin of 59.1%, and ROIC of 6.1%. By comparison, DE (Deere & Company) holds a C+ grade (66/100 RQD, P/E 35.4x, ROIC 9.3%, cap $177.95B) and TMO (Thermo Fisher Scientific Inc) posts a B grade (73/100 RQD, P/E 39.0x, ROIC 9.3%, cap $262.22B). Among the 5-stock peer group, ITW leads on earnings multiple (24.3x) while ITW leads on capital efficiency (23.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for DHR?
Per DHR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000313616), Danaher Corporation generated $24.57B in revenue (+2.9% YoY), $3.61B in net income, and $5.26B in free cash flow against $83.46B in total assets and $18.42B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 46x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is DHR trading relative to its 50-day, 200-day, and 52-week technical levels?
DHR last traded at $232.23 (-2.00% on volume of 3,755,006 shares), positioning the stock +5.73% above its 50-day simple moving average ($219.65) and +15.48% above its 200-day simple moving average ($201.10). Across its 52-week range of $160.93 to $242.80, DHR sits at the 87.1% percentile with a 14-day RSI of 62.5 (BULLISH MOMENTUM) and an implied next-earnings move of ±5.8% ($218.76 to $245.70).
DHR Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is DHR stock moving today?
Why DHR Stock dropped -2.00% Today — RQD Quant Desk Flash. High-quality cash engine (59% profit margin, 6% return on capital) with steady institutional support.
DHR — Danaher Corporation: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, DHR scores 70 out of 100, a B- grade labeled "Roarable Buy — Sound Institutional Accumulation." The five pillars are: Fundamental Cash Engine at 13/20 (ROIC 6.1%; FCF yield 3.15%), Whale 13F Flow at 19/20 (institutional accumulation and options positioning), Insider Conviction at 11/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 13/20 (Beta 0.9; sector sensitivity), and Forensic Balance Sheet at 14/20 (Altman Z 3.85; Piotroski F 7/9; Debt/Equity 0.35).
For a prospective investor, the strongest pillar is institutional flow, which the rating places near its maximum. The cash-generation and macro-fit pillars sit in the middle of the range, and the ROIC and FCF yield figures signal that the valuation is rich relative to current cash returns. Per the market data, the P/E (TTM) is 46.1 and the forward P/E is 42.9, so upside depends heavily on earnings growth materializing rather than on multiple support. The forensic balance sheet is comparatively sound per the rating's inputs. Insider conviction is moderate. This is an educational reading of the scores, not personalized advice.
Snapshot
Business
Per the profile, Danaher Corporation is a NYSE-listed issuer in the Industrials sector, specifically Industrial Machinery/Components. Per the Butterfly Supply-Chain Graph, the Biotechnology Segment's bioprocessing business is referenced as a supplier of chromatography resins and single-use filtration consumables. Not available in source data for the detailed product lines, customer base beyond the referenced Novo Nordisk relationship, or revenue mix by segment.
Recent Catalysts & News Wire Analysis
Per the recent news feed, the headlines include a Yahoo Finance report on a recovery in pricing, a Seeking Alpha report describing a drop after a Q3 revenue miss amid a CEO transition (flagged RED / RISK WATCH), a Yahoo Finance report questioning the valuation, a Benzinga report on same-day stock movement, a Simply Wall St forecast piece, and a Stock Titan report on an EVP's sale of 15,603 shares after exercising options at $76.47 per share. The Q3 revenue miss and CEO transition are the principal risk-watch items. Per the Butterfly Supply-Chain Graph, one analyst-hypothesis link (evidence tier: ANALYST_HYPOTHESIS) connects DHR to NVO through a DIRECT_SUPPLIER relationship with a TAILWIND direction, with the next catalyst listed as the Danaher Biotechnology Segment Bioprocessing Consumables Order Book-to-Bill print. Proprietary signals are empty per the graph. The exposure percentage is undisclosed.
Open Questions
- What is the current consensus analyst rating and price target, given that analyst data is absent from the sources?
- What are the actual 13F institutional holder names and share changes behind the Whale Flow pillar score of 19/20?
- What was the scope and magnitude of the Q3 revenue miss and CEO transition referenced in the news feed?
- What are the reported EPS and cash balances for each fiscal period, which are currently N/A in the financials?
- What is the exposure percentage of DHR's bioprocessing business to the GLP-1 supply chain, which the graph lists as undisclosed?
DHR Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Danaher Corporation (DHR) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Benzinga report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
Kalkine Media report covering Danaher Corporation (DHR) market action, institutional positioning, and fundamental catalysts.
DHR Bull vs. Bear Conversation Board — What's Your Call at $232.23?
🔥 Official Bull vs. Bear Debate: Is DHR (B- • RQD 70/100) a Buy at $236.98?
Welcome to the DHR (Danaher Corporation) Roar Pit. Current RQD Composite is 70/100 (Roarable Buy — Sound Institutional Accumulation) in Industrial Machinery/Components. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (46.1x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on DHR — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on DHR, but look at what you are paying: 46.1x trailing P/E with 59.1% gross margins. Unless Danaher Corporation expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
DHR cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on DHR, the market is fixating on short-term headline noise in Industrial Machinery/Components and ignoring the balance sheet and cash flow trajectory. At $236.98 (52-wk range $160.93 - $242.80), any beat on forward guidance forces shorts and underweight funds to chase.